Parasites, Hosts and Diseases

The Korea Society for Parasitology and Tropical Medicine (대한기생충학·열대의학회)
권호 표지

Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hyper-sensitivity in BALB/c mice

  • Published : 2007.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Leishmania tropica and L. major are etiologic agents of human cutaneous leishmaniasis. Delayed type hypersensitivity (DTH) is an immunologic response that has been frequently used as a correlate for protection against or sensitization to leishmania antigen. In BALB/c mice, L. tropica infection results in non-ulcerating disease, whereas L. major infection results in destructive lesions. In order to clarify the immunologic mechanisms of these 2 different outcomes, we compared the ability of these 2 leishmania species in induction of DTH response in this murine model. BALB/c mice were infected with L. major or L. tropica, and disease evolution and DTH responses were determined. The results show that the primary L. major infection can exacerbate the secondary L. major infection and is associated with DTH response. Higher doses of the primary L. major infection result in more disease exacerbation of the secondary L. major infection as well as higher DTH response. L. tropica infection induces lower DTH responses than L. major. We have previously reported that the primary L. tropica infection induces partial protection against the secondary L. major infection in BALB/c mice. Induction of lower DTH response by L. tropica suggests that the protection induced against L. major by prior L. tropica infection may be due to suppression of DTH response.

Keywords

References

  1. Abbas AK, Litchman AH (2004) Cellular and Molecular Immunology, 5th ed. pp 306-308, Elsevier Science (USA), Philadelphia, USA
  2. Babay BE, Louzir H, Kebaier C, Boubaker S, Dellagi K, Cazenave PA (2004) Inbred strains derived from feral mice reveal new pathogenic mechanisms of experimental leishmaniasis due to Leishmania major. Infect Immun 72: 4603-4611 https://doi.org/10.1128/IAI.72.8.4603-4611.2004
  3. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H (1992) Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 257: 539-542 https://doi.org/10.1126/science.1636090
  4. Compton HL, Farrell JP (2002) CD28 costimulation and parasite dose combine to influence the susceptibility of BALB/c mice to infection with Leishmania major. J Immunol 168: 1302-1308 https://doi.org/10.4049/jimmunol.168.3.1302
  5. Convit J, Ulrich M, Fernandez CT, Tapia FJ, Caceres-Dittmar G, Castes M, Rondon AJ (1993) The clinical and immunological spectrum of american cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 87: 444-448 https://doi.org/10.1016/0035-9203(93)90030-T
  6. Courret N, Lang T, Milon G, Antoine JC (2003) Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice. Int J Parasitol 33: 1373-1383 https://doi.org/10.1016/S0020-7519(03)00179-6
  7. De Rossell RA, Bray RS, Alexander J (1987) The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis. Parasite Immunol 9: 105-115 https://doi.org/10.1111/j.1365-3024.1987.tb00492.x
  8. Dhaliwal JS, Liew FY (1987) Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis. Infect Immun 55: 645- 651
  9. Dhaliwal JS, Liew FY, Cox FE (1985) Specific suppressor T cells for delayed-type hypersensitivity in susceptible mice immunized against cutaneous leishmaniasis. Infect Immun 49: 417-423
  10. Doherty TM, Coffman RL (1996) Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice. Exp Parasitol 84: 124-135 https://doi.org/10.1006/expr.1996.0098
  11. Howard JG, Hale C, Liew FY (1980) Immunologic regulation of experimental cutaneous leishmaniasis, III. Nature and significance of specific suppression of cell-mediated immunity. J Exp Med 152: 594-607 https://doi.org/10.1084/jem.152.3.594
  12. Liew FY, Dhaliwal JS (1987) Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites. J Immunol 138: 4450-4456
  13. Liew FY, Singleton A, Cillari E, Howard JG (1985) Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection. J Immunol 135: 2102-2107
  14. Lira R, Mendez S, Carrera L, Jaffe C, Neva F, Sacks D (1998) Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease. Exp Parasitol 89: 331-342 https://doi.org/10.1006/expr.1998.4283
  15. Mahmoudzadeh-Niknam H (2004) Induction of partial protection against Leishmania major in BALB/c mice by Leishmania tropica. Scand J Lab Anim Sci 31: 201-207
  16. Mahmoudzadeh-Niknam H, McKerrow JH (2004) Leishmania tropica: cysteine proteases are essential for growth and pathogenicity. Exp Parasitol 106: 158-163 https://doi.org/10.1016/j.exppara.2004.03.005
  17. Saha B, Tonkal AMDJ, Croft S, Roy S (2004) Mast cells at the host-pathogen interface: host-protection versus immune evasion in leishmaniasis. Clin Exp Immunol 137: 19-23 https://doi.org/10.1111/j.1365-2249.2004.02505.x